Market Research Logo

Pakistan Pharmaceuticals & Healthcare Q4 2018

Pakistan Pharmaceuticals & Healthcare Q4 2018

Key View:

Given systemic problems with intellectual property protection and the high prevalence of counterfeit medicines inparticular, Pakistan's pharmaceutical market will remain a low priority for innovative drugmakers, especially in light of the uncertainpolicy directions. In addition, the Pakistan-Tehreek-e-Insaf (PTI) political party is expected to upscale health coverage, increase thenumber of emergency units and generally implement programmes to improve health outcomes. Furthermore, the country's rapidlyexpanding population suggests strong development potential, though makers of innovative medicines are bound to remain varyof launching new innovative treatments in Pakistan.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Asia Pacific Innovative Pharmaceuticals & Healthcare Risk/Reward Index
Pakistan Pharmaceuticals Industry Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Abbott Laboratories (Pakistan)
Efroze Chemical Industries
Ferozsons Laboratories
Getz Pharma
GlaxoSmithKline
Hilton Pharma
Novartis Pakistan
Pfizer Pakistan Limited
Sanofi-Aventis
SEARLE Company Limited
Pakistan Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report